STOCK EXCHANGE INTIMATION 2026-2027
Shareholding Pattern
- Shareholding Pattern for the Quarter ended 30th September 2026
- Shareholding Pattern for the Quarter ended 30th June 2026
Intimation of Board Meeting-
- Intimation of Board Meeting dated 09th October 2026
- Intimation of Board Meeting dated 14th July 2026
- Intimation of Board Meeting dated 02nd May 2026
Outcome of Board Meeting-
- Outcome of Board Meeting dated 17th October 2026
- Outcome of Board Meeting dated 20th July 2026
- Outcome of Board Meeting dated 8th May 2026
Financial Results-
- Financial Results- 30th September 2026
- Financial Results-30th June 2026
- Financial Results-31st March 2026
Newspaper Publication for Results-
- Newspaper Publication for 30th September 2026 Results
- Newspaper Publication for 30th June 2026 Results
- Newspaper Publication for 31st March 2026 Results
General Updates Under Regulation 30 of SEBI (LODR) Regulations, 2015-
- Intimation for Transcript of Earnings Call for Q2FY27
- Intimation for Audio Recording of Earnings Call for Q2FY27
- Earning updates for the quarter ended 30th September 2026
- Intimation for Earnings Call for Q2 & H1 FY27
- Intimation of Final Order of the Hon’ble NCLT approving the acquisition of Genrx Pharmaceuticals Private Limited
- Intimation for Sale of an Undertaking of the Company
- Intimation for allotment of equity shares upon exercise of ESOPs
- Intimation for approval received from DCGI to manufacture and market Cenobamate API & Tablets.
- Credit Rating
- Intimation for Transcript of Earnings call for Q1FY27
- Intimation for Audio Recording of Earnings Call for Q1FY27
- Intimation for Grant of Employee Stock Options under “Bajaj Healthcare Limited Employee Stock Option Plan 2024”
- Earning updates for the quarter ended 30th June 2026
- Intimation for Earnings Call for Q1FY27
- Intimation for recommendation received from SEC-CDSCO to manufacture and market Cenobamate Tablets.
- Intimation for Sale of Business Unit of the Company
- Earning updates for the quarter & year ended 31st March 2026
- Intimation of Approval received for Listing of 20,79,409 equity shares of ₹5/- each allotted pursuant to conversion of warrants issued on preferential basis
Annual Secretarial Compliance Report-
Trading Window Closure-
- Intimation for closure of Trading Window for the Quarter ended September 30, 2026
- Intimation for closure of Trading Window for the Quarter ended June 30, 2026
Compliance Certificate
- Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30th September 2026
- Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30th June 2026
Monitoring Agency Report
Integrated Filing (Financial)
- Integrated Filing for the quarter ended 30th September 2026
- Integrated Filing for the quarter ended 30th June 2026
Statement of Deviation & Variation
- Statement of Deviation & Variation for the period ended 30th September 2026
- Statement of Deviation & Variation for the period ended 30th June 2026
Earnings Call
- Transcript of Earnings Call for Q2FY27
- Audio Recording of Earnings call for Q2FY27
- Audio Recording of Earnings call for Q1FY27
- Transcript of Earnings call for Q1FY27
33rd Annual General Meeting
- Intimation for Voting Results & Scrutinizer’s Report
- Outcome of the AGM
- Intimation of Record Date for the payment of Final Dividend
- Annual Report
- Intimation for Newspaper Publication (Post Dispatch)
- Intimation for Notice of 33rd AGM
- Intimation for Annual Report FY2026
- Intimation for BRSR FY 2026
- Intimation for Inland Letters sent to SH
- Business Responsibility and Sustainability Report FY2026
- Intimation for Newspaper Publication (Pre-Dispatch)
- Draft Annual Return
Integrated Filing (Governance)
- Integrated Filing for the quarter ended 30th September 2026
- Integrated Filing for the quarter ended 30th June 2026
Reconciliation of Share Capital Audit Report